This application is a proposal for a renewal of our program project, Healthy Aging and Senile Dementia (HASD). The program project began as an expansion of longitudinal studies of subjects with mild senile dementia of the Alzheimer type (SDAT) and matched healthy control subjects. In this renewal there is a continued focus on the behavioral and biomedical correlates of the clinical course of defined groups of SDAT subjects in comparison with the course of healthy aging in control subjects, Five interactive and supportive Cores are proposed: Clinical, Psychometric, Neuropathology, Biostatistics and Administration. Three of our current projects are to continue. Project 1 will continue to study demented and nondemented subjects aged 80 and over with respect to their longitudinal clinical and psychometric performance during life, neuropathologic data postmortem, and their interrelationships.
The aim i s to develop and help validate guidelines for separating Alzheimer's disease (AD) from nonAD in the very old. In Project 2 there will continue a study of the distribution and density of plaques, tangles and related immunohistochemical markers in the ventral forebrain of carefully assessed demented and nondemented old individuals. The goal is to define the pattern of pathologic changes in the earliest stage of AD by concentrating on very old nondemented subjects. Project 3 will build on current results that suggest very mild and mild SDAT subjects exhibit breakdown in the inhibitory control of irrelevant representation during memory processing. Utilizing basic healthy aging and mild SDAT. Based on preliminary results that indicate normal elderly and very mild SDAT subjects show improved memory with optimal elevations (different for each group) of plasma glucose, Project 4 will study the effect of hyperglycemia on memory performance and glucoregulatory hormone levels in those subjects groups in longitudinal experiments. Simultaneously, the effects of increased insulin levels on memory performance will also be assessed.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG003991-14
Application #
2001174
Study Section
Neuroscience, Behavior and Sociology of Aging Review Committee (NBSA)
Project Start
1984-01-01
Project End
1998-12-31
Budget Start
1997-01-01
Budget End
1997-12-31
Support Year
14
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Washington University
Department
Neurosurgery
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Roe, Catherine M; Babulal, Ganesh M; Mishra, Shruti et al. (2018) Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease. J Alzheimers Dis 61:509-513
Rao, Shuquan; Ghani, Mahdi; Guo, Zhiyun et al. (2018) An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk. Neurobiol Aging 66:178.e1-178.e8
Laurido-Soto, Osvaldo; Brier, Matthew R; Simon, Laura E et al. (2018) Patient characteristics and outcome associations in AMPA receptor encephalitis. J Neurol :
Peloso, Gina M; van der Lee, Sven J; International Genomics of Alzheimer's Project (IGAP) et al. (2018) Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease. Alzheimers Dement (Amst) 10:595-598
Armstrong, Richard A; McKee, Ann C; Stein, Thor D et al. (2018) Cortical degeneration in chronic traumatic encephalopathy and Alzheimer's disease neuropathologic change. Neurol Sci :
Sato, Chihiro; Barthélemy, Nicolas R; Mawuenyega, Kwasi G et al. (2018) Tau Kinetics in Neurons and the Human Central Nervous System. Neuron 98:861-864
Deming, Yuetiva; Li, Zeran; Benitez, Bruno A et al. (2018) Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease? Expert Opin Ther Targets 22:587-598
Millar, Peter R; Balota, David A; Bishara, Anthony J et al. (2018) Multinomial models reveal deficits of two distinct controlled retrieval processes in aging and very mild Alzheimer disease. Mem Cognit 46:1058-1075
Musiek, Erik S; Bhimasani, Meghana; Zangrilli, Margaret A et al. (2018) Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer Disease. JAMA Neurol 75:582-590
Vlassenko, Andrei G; Gordon, Brian A; Goyal, Manu S et al. (2018) Aerobic glycolysis and tau deposition in preclinical Alzheimer's disease. Neurobiol Aging 67:95-98

Showing the most recent 10 out of 911 publications